Access Vascular, Inc.
PrivateLast Round
Series C
Oct 31, 2023
Total Funding Raised
$45.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Access Vascular, Inc. operates in Healthcare & Life Sciences and is based in Billerica, Massachusetts. Its latest recorded funding round was a Series C round in October 2023.
Access Vascular, Inc. is a medical device company that develops and manufactures a suite of venous access devices, including PICCs and midlines, using proprietary hydrophilic biomaterial technology to reduce vascular access complications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Access Vascular, Inc. Comparables
Compare Access Vascular, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomend | 82% | |
| Medical Components, Inc. | 79% | |
| Shandong Weigao Group Medical Polymer Co Ltd | 76% |
For institutional investors. Book with your work email.
Access Vascular, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 31, 2023 | ||||
| Series B | Mar 3, 2021 | ||||
| VC Round | Sep 26, 2019 | ||||
| VC Round | Oct 2, 2018 | ||||
| Angel | Aug 29, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Access Vascular, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TVM Capital | Series C, Series B |
| Green Park & Golf Ventures | Series C |
| AngelMD | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 39% MoM, from 3.6K to 5K.
- Oct 31, 2023
$22M round with Green Park & Golf Ventures and TVM Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientSep 15, 2026
Access Vascular, Inc. receives an Innovative Technology contract from Vizient for its HydroMID(R) Midline Catheter, following evaluation by hospital experts, in Massachusetts on Sep 15th '26.
For institutional investors. Book with your work email.
Access Vascular, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Access Vascular, Inc.'s valuation, stock price, and market status.
Is Access Vascular, Inc. a public or private company?
Access Vascular, Inc. is a private company.
What is the current stock price of Access Vascular, Inc.?
Access Vascular, Inc. is a private company, so its shares have no public market price. Caplight tracks Access Vascular, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Access Vascular, Inc. worth (valuation)?
Valuation information for Access Vascular, Inc. is not publicly available.
Can I buy Access Vascular, Inc. stock?
Access Vascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Access Vascular, Inc.'s last funding round?
Access Vascular, Inc.'s most recent funding round was Series C on October 31, 2023.
Who are the main investors in Access Vascular, Inc.?
Key investors in Access Vascular, Inc. include TVM Capital.
Will Access Vascular, Inc. IPO soon?
No public IPO plans have been announced for Access Vascular, Inc..
How can I track Access Vascular, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Access Vascular, Inc.'s shares on secondary markets.